Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria

Gastroenterology

Volumn 140, Issue 5, 2011, Pages 1472-1480

  Czaja, Albert J ^a,b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

Clinical Phenotypes; Diagnostic Classifications; Scoring Systems; Treatment Responses

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN G; PREDNISONE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; DIAGNOSTIC SCORING SYSTEM; FEMALE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROBABLE AUTOIMMUNE HEPATITIS; SCORING SYSTEM; TREATMENT RESPONSE;

EID: 79955383556     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.02.010     Document Type: Article

References (36)

1. F. Alvarez, P.A. Berg, and F.B. Bianchi International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938 (Pubitemid 29514229)
2. E.M. Hennes, M. Zeniya, and A.J. Czaja Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 2008 169 176 (Pubitemid 351975541)
3. A.D. Yeoman, R.H. Westbrook, and T. Al-Chalabi Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease Hepatology 50 2009 538 545
4. M.P. Manns, A.J. Czaja, and J.D. Gorham Practice Guidelines of the American Association for the Study of Liver Diseases Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
5. A.J. Czaja, and M.P. Manns Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis Gastroenterology 139 2010 58 72
6. A.J. Czaja The variant forms of autoimmune hepatitis Ann Intern Med 125 1996 588 598 (Pubitemid 126450092)
7. A.J. Czaja Frequency and nature of the variant syndromes of autoimmune liver disease Hepatology 28 1998 360 365 (Pubitemid 28363659)
8. A.J. Czaja Performance parameters of the diagnostic scoring systems for autoimmune hepatitis Hepatology 48 2008 1540 1548
9. L. Muratori, M. Cataleta, and P. Muratori Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis Gut 42 1998 721 726 (Pubitemid 28261064)
10. A.J. Czaja Behavior and significance of autoantibodies in type 1 autoimmune hepatitis J Hepatol 30 1999 394 401 (Pubitemid 29113226)
11. S. Luth, J. Herkel, and S. Kanzler Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis J Clin Gastroenterol 42 2008 926 930
12. A.J. Czaja, G.L. Davis, and J. Ludwig Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology Gastroenterology 85 1983 713 717 (Pubitemid 13033133)
13. A.J. Czaja, A.M. Wolf, and A.H. Baggenstoss Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features Gastroenterology 80 1981 687 692 (Pubitemid 11137747)
14. A.J. Czaja, and H.A. Homburger Autoantibodies in liver disease Gastroenterology 120 2001 239 249 (Pubitemid 32061888)
15. A.J. Montano-Loza, H.A. Carpenter, and A.J. Czaja Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis J Clin Gastroenterol 42 2008 1047 1053
16. A.J. Czaja, and H.A. Carpenter Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis Gastroenterology 105 1993 1824 1832 (Pubitemid 24002801)
17. R.D. Soloway, A.H. Baggenstoss, and L.J. Schoenfield Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy Am J Dig Dis 16 1971 1082 1086
18. A.J. Czaja Treatment of autoimmune hepatitis Semin Liver Dis 22 2002 365 378
19. W.H. Summerskill, M.G. Korman, and H.V. Ammon Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared Gut 16 1975 876 883
20. A.J. Montano-Loza, H.A. Carpenter, and A.J. Czaja Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse Am J Gastroenterol 102 2007 1005 1012 (Pubitemid 46698236)
21. A.J. Montano-Loza, H.A. Carpenter, and A.J. Czaja Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease Hepatology 46 2007 1138 1145 (Pubitemid 350144778)
22. A.J. Czaja, H.A. Carpenter, and P.J. Santrach Significance of HLA DR4 in type 1 autoimmune hepatitis Gastroenterology 105 1993 1502 1507 (Pubitemid 23315327)
23. A.J. Czaja, M.D. Strettell, and L.J. Thomson Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis Hepatology 25 1997 317 323 (Pubitemid 27069049)
24. P.T. Donaldson, D.G. Doherty, and K.M. Hayllar Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors Hepatology 13 1991 701 706
25. A.J. Czaja, H.A. Carpenter, and P.J. Santrach The nature and prognosis of severe cryptogenic chronic active hepatitis Gastroenterology 104 1993 1755 1761 (Pubitemid 23235469)
26. D.J. Gassert, H. Garcia, and K. Tanaka Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis Dig Dis Sci 52 2007 2433 2437 (Pubitemid 47246512)
27. S. Heringlake, A. Schutte, and P. Flemming Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology Z Gastroenterol 47 2009 417 423
28. R. Perdigoto, H.A. Carpenter, and A.J. Czaja Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis J Hepatol 14 1992 325 331
29. R. Abdalian, P. Dhar, and K. Jhaveri Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging Hepatology 47 2008 949 957 (Pubitemid 351449686)
30. J.A. Talwalkar, J.C. Keach, and P. Angulo Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system Am J Gastroenterol 97 2002 1191 1197 (Pubitemid 34478121)
31. K.M. Boberg, O. Fausa, and T. Haaland Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis Hepatology 23 1996 1369 1376 (Pubitemid 26181218)
32. S. Nezu, A. Tanaka, and H. Yasui Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis J Gastroenterol Hepatol 21 2006 1448 1454 (Pubitemid 44154715)
33. S. Mishima, K. Omagari, and K. Ohba Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study Hepatogastroenterology 55 2008 221 227 (Pubitemid 351462195)
34. C. O'Brien, S. Joshi, and J.J. Feld Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis Hepatology 48 2008 550 556
35. D.C. Rockey, L.B. Seeff, and J. Rochon Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method Hepatology 51 2010 2117 2126
36. R.V. Lenth Statistical power calculations J Anim Sci 85 2007 E24 E29